Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTK6 | Q13882 | 12/20 | 0.39 |
| ▸ | AURKB | Q96GD4 | 6/20 | 0.35 |
| ▸ | LCK | P06239 | 4/20 | 0.33 |
| ▸ | TTK | P33981 | 4/20 | 0.32 |
| ▸ | MAPKAPK5 | Q8IW41 | 2/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22123395 | 0.94 | PTK6 (0.39) | PTK6AURKBLCKTTKMAPKAPK5 | |
| SCHEMBL22123411 | 0.89 | PTK6 (0.40) | PTK6AURKBLCKTTKMAPKAPK5 | |
| SCHEMBL30171772 | 0.89 | PTK6 (0.40) | PTK6AURKBLCKTTKMAPKAPK5 | |
| SCHEMBL24870995 | 0.89 | PTK6 (0.40) | PTK6AURKBLCKTTKMAPKAPK5 | |
| SCHEMBL22123256 | 0.83 | PTK6 (0.55) | PTK6AURKBLCK | |
| SCHEMBL24870811 | 0.82 | PTK6 (0.40) | PTK6AURKBLCKTTKMAPKAPK5 | |
| SCHEMBL22123396 | 0.82 | PTK6 (0.40) | PTK6AURKBLCKTTKMAPKAPK5 | |
| SCHEMBL30171918 | 0.82 | PTK6 (0.40) | PTK6AURKBLCKTTKMAPKAPK5 | |
| SCHEMBL25173677 | 0.82 | TTK (0.40) | PTK6TTKMAPKAPK5PDE4BPDE4D | |
| SCHEMBL22124105 | 0.82 | PTK6 (0.55) | PTK6AURKBLCKMAPKAPK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3898631-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS | F. Hoffmann-La Roche AG (CH) | 2021-10-27 | — | — | EP | claimed |
| WO-2020126953-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS | F. HOFFMANN-LA ROCHE AG (CH) | 2020-06-25 | — | — | WO | claimed |